Concepedia

Amy C. Doty

AC

Statistics

Publications

11

Citations

561

H-Index

10

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

BioSurfaces (United States)

University of Michigan

Center for Drug Evaluation and Research

Discovery Laboratories (United States)

Amy C. Doty is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, drug delivery, and pharmacology.

ORCID

Publications per year

2011–2021

11

Publications

11

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

Bryce Chiang, Y.C. Kim, Amy C. Doty et al. · Journal of Controlled Release · 2016 · 95 citations

, , +12

Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres

Amy C. Doty, David G. Weinstein, Keiji Hirota et al. · Journal of Controlled Release · 2017 · 91 citations

, , +16

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 87 citations · Full text

, , +12

Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation

Keiji Hirota, Amy C. Doty, Rose Ackermann et al. · Journal of Controlled Release · 2016 · 80 citations

, , +16

Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions

Amy C. Doty, Ying Zhang, David G. Weinstein et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2016 · 44 citations

, , +17

1–5 of 11